Stock Price Quote

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE233.45-0.5 (-0.21 %)
PREV CLOSE ( ) 233.95
OPEN PRICE ( ) 239.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36470
TODAY'S LOW / HIGH ( )226.00 240.00
52 WK LOW / HIGH ( )119 265
NSE233.45-0.75 (-0.32 %)
PREV CLOSE( ) 234.20
OPEN PRICE ( ) 240.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 233.45 (54)
VOLUME 306141
TODAY'S LOW / HIGH( ) 230.60 240.35
52 WK LOW / HIGH ( )126.65 265
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
Soshil Kumar Jain - Chairman Rajesh Jain - Managing Director
Registered Office

Address Ambala - Chandigarh Highway,,,
Lalru,
Punjab-140501

Phone 01762- 505900

Email investorgrievances@panaceabiotec.com

Website www.panacea-biotec.com

Registrars Details
Skyline Financial Services Pvt Ltd
D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE, MCX

NEWS

08Apr Clarification sought from Panacea Bio
The Exchange has sought clarification from Panacea Biotec Ltd on April 8..
06Apr Panacea Biotec, RDIF agree to produce
Panacea Biotec and the Russian Direct Investment Fund (RDIF, Russia's so..
05Apr Announcement under Regulation 30 (LOD
Panacea Biotec Ltd. ('PBL') is delighted to announce that the Russian Di..
05Oct Panacea Biotec gets warning letter fro
Panacea Biotec has received warning letter from US Food and Drug Adminis..
24Sep Panacea Biotec completes Phase 1/11 st
Panacea Biotec has successfully completed its Phase I/II study to evalua..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit19-1530.8
Gross Profit 19.1 -789.300000000001
Operating Profit 104.4-313.5
Net Sales 690.21580.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15245.80 (1.32%)
M.Cap ( in Cr)32396.26
Pfizer (BSE)
peergroup  4797.80 (3.88%)
M.Cap ( in Cr)21948.85
Alkem Laboratories (BSE)
peergroup  2832.25 (4.66%)
M.Cap ( in Cr)33863.80
Sanofi India (BSE)
peergroup  8227.25 (1.04%)
M.Cap ( in Cr)18947.87
Procter&Gamble Healt (BSE)
peergroup  6362.40 (1.17%)
M.Cap ( in Cr)10561.19

Shareholding Pattern

PROMOTERS 73.59%
NON-INSTITUTION 25.02%
MUTUAL FUNDS/UTI 1.28%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
ICICI Pru Pharma He...0.87

About Panacea Biotec Ltd.

Panacea Biotec Ltd. was incorporated in the year 1984. Its today's share price is 233.45. Its current market capitalisation stands at Rs 1429.9 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4896.78 Cr and Total Income of Rs.5335.83 Cr. The company's management includes Vinod Goel, Shantanu Yeshwant Nalavadi, R L Narasimhan, N N Khamitkar, Mukul Gupta, Manjula Upadhyay, K M Lal, Bhupinder Singh, Ashwini Luthra, Ankesh Jain, Sandeep Jain, Rajesh Jain, Soshil Kumar Jain.

It is listed on the BSE with a BSE Code of 531349 , NSE with an NSE Symbol of PANACEABIO and ISIN of INE922B01023. It's Registered office is at Ambala - Chandigarh Highway,,Lalru-140501, Punjab. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Co LLP, Walker Chandiok & Co, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)